Clinical Trial Update: Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the tubular effects of dapagliflozin using 1H NMR spectroscopy in diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Ioannina | Conditions: Diabetes | Phase 4 | Status: COMPLETED